Cargando…

Immune Resistance in Lung Adenocarcinoma

SIMPLE SUMMARY: Lung adenocarcinoma (LUAD) is the major subtype of lung cancer and represents the deadliest human cancer, affecting current-, ex-, and even non-smokers. LUAD is driven by the accumulation of mutations in several different genes, which results in uncontrolled proliferation of the lung...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spella, Magda, Stathopoulos, Georgios T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864325/ https://www.ncbi.nlm.nih.gov/pubmed/33494181 http://dx.doi.org/10.3390/cancers13030384

Ejemplares similares

A role for club cells in smoking-associated lung adenocarcinoma
por: Behrend, Sabine J., et al.
Publicado: (2021)

Shared epithelial pathways to lung repair and disease
por: Spella, Magda, et al.
Publicado: (2017)

Interleukin-1β provided by KIT-competent mast cells is required for KRAS-mutant lung adenocarcinoma
por: Lilis, Ioannis, et al.
Publicado: (2019)

Comprehensive Evaluation of Nuclear Factor-κΒ Expression Patterns in Non-Small Cell Lung Cancer
por: Giopanou, Ioanna, et al.
Publicado: (2015)

Wnt1 silences chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma
por: Kerdidani, Dimitra, et al.
Publicado: (2019)

Club cells form lung adenocarcinomas and maintain the alveoli of adult mice
por: Spella, Magda, et al.
Publicado: (2019)

Beneficial Impact of CCL2 and CCL12 Neutralization on Experimental Malignant Pleural Effusion
por: Marazioti, Antonia, et al.
Publicado: (2013)

The multi-faceted functioning portrait of LRF/ZBTB7A
por: Constantinou, Caterina, et al.
Publicado: (2019)

NRAS destines tumor cells to the lungs
por: Giannou, Anastasios D, et al.
Publicado: (2017)

MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically
por: Munkhbaatar, Enkhtsetseg, et al.
Publicado: (2020)

Caspase-11 and AIM2 inflammasome are involved in smoking-induced COPD and lung adenocarcinoma
por: Colarusso, Chiara, et al.
Publicado: (2021)

Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma
por: Neel, Dana S., et al.
Publicado: (2017)

Role of exosomal microRNAs in lung cancer biology and clinical applications
por: Hu, Chengping, et al.
Publicado: (2020)

KRAS Pathway Alterations in Malignant Pleural Mesothelioma: An Underestimated Player
por: Trassl, Lilith, et al.
Publicado: (2022)

Drug resistance mechanisms and progress in the treatment of EGFR-mutated lung adenocarcinoma
por: Sun, Ruizhu, et al.
Publicado: (2022)

Hepatoid Adenocarcinoma of the Lung
por: Li, Meihui, et al.
Publicado: (2021)

JAG1 is correlated to suppressive immune microenvironment and predicts immunotherapy resistance in lung adenocarcinoma
por: He, Jing, et al.
Publicado: (2023)

Prognostic value of the immune microenvironment in lung adenocarcinoma
por: Kadota, Kyuichi, et al.
Publicado: (2013)

An individualized immune prognostic signature in lung adenocarcinoma
por: Sun, Liangdong, et al.
Publicado: (2020)

The tumor microenvironment of pancreatic adenocarcinoma and immune checkpoint inhibitor resistance: a perplex relationship
por: Sahin, Irem, et al.
Publicado: (2020)

The distinctive nature of adenocarcinoma of the lung
por: Roviello, Giandomenico
Publicado: (2015)

Regulation of Ferroptosis in Lung Adenocarcinoma
por: Wei, Xiangyun, et al.
Publicado: (2023)

Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma
por: Chang, Yoon Soo, et al.
Publicado: (2016)

Metformin Induces Resistance of Cancer Cells to the Proteasome Inhibitor Bortezomib
por: Schlesser, Camille, et al.
Publicado: (2022)

Ferroptosis-Related Genes in Lung Adenocarcinoma: Prognostic Signature and Immune, Drug Resistance, Mutation Analysis
por: Ren, Ziyuan, et al.
Publicado: (2021)

A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma
por: Zhu, Liping, et al.
Publicado: (2021)

The CDK1-Related lncRNA and CXCL8 Mediated Immune Resistance in Lung Adenocarcinoma
por: Xue, Jinmin, et al.
Publicado: (2022)

Comprehensive clinical profiling of the Gauting locoregional lung adenocarcinoma donors
por: Klotz, Laura V., et al.
Publicado: (2019)

Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion
por: Marazioti, Antonia, et al.
Publicado: (2018)

Breaking the Invisible Barriers: Unleashing the Full Potential of Immune Checkpoint Inhibitors in Oncogene-Driven Lung Adenocarcinoma
por: Kwok, Hoi-Hin, et al.
Publicado: (2023)

Advances in deubiquitinating enzymes in lung adenocarcinoma
por: Zhou, Xi-Jia, et al.
Publicado: (2021)

Comprehensive review of fetal adenocarcinoma of the lung
por: Ricaurte, Luisa María, et al.
Publicado: (2018)

Emerging genetic biomarkers in lung adenocarcinoma
por: Barbar, Jawad, et al.
Publicado: (2022)

Identification of prognostic genes in lung adenocarcinoma immune microenvironment
por: Han, Lian-Kui, et al.
Publicado: (2021)

The screening of immune-related biomarkers for prognosis of lung adenocarcinoma
por: Liu, Zhonghui, et al.
Publicado: (2021)

Alternative Splicing Events in Immune Infiltration of Lung Adenocarcinoma
por: Huang, Tianpeng, et al.
Publicado: (2021)

Profiles of Immune Infiltration and Prognostic Immunoscore in Lung Adenocarcinoma
por: Li, Yanyan, et al.
Publicado: (2020)

Prognostic value of immune related genes in lung adenocarcinoma
por: Wang, Han, et al.
Publicado: (2020)

Genomic and immune profiling of pre-invasive lung adenocarcinoma
por: Chen, Haiquan, et al.
Publicado: (2019)

Comprehensive analysis of Cuproplasia and immune microenvironment in lung adenocarcinoma
por: Kuang, Junjie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2qdmi92uns08jau0cl3fil2o61